• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

3 Diets That May Ward Off Dementia and Heart Disease — and 1 That Hastens Them

September 24, 2025

21 Thrift Store Gems You Can Cash in On

September 24, 2025

Principles For A Successful Financial Year

September 23, 2025
Facebook Twitter Instagram
Trending
  • 3 Diets That May Ward Off Dementia and Heart Disease — and 1 That Hastens Them
  • 21 Thrift Store Gems You Can Cash in On
  • Principles For A Successful Financial Year
  • 10 Things You Can Get for Free at Pharmacies
  • Nearly Half of Workers Admit to Revenge Quitting. Here’s Why.
  • Build-A-Bear Workshop Outpaces Nvidia, Microsoft, Oracle
  • Spirit Airlines Furloughing Flight Attendants, Cutting Routes
  • Stellantis Data Breach Affects Millions of Car Buyers: Report
Wednesday, September 24
Facebook Twitter Instagram
FintechoPro
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
FintechoPro
Home » Ozempic and Other Weight-Loss Drugs Have Pummeled This Stock. It May Be a Buy.
Investing

Ozempic and Other Weight-Loss Drugs Have Pummeled This Stock. It May Be a Buy.

News RoomBy News RoomSeptember 27, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

RBC Capital Markets analyst Nik Modi gives Utz a $17 price target.


Dreamstime

Utz Brands
stock has taken a hit this year, but one analyst says now is the time to buy shares of the snack maker.

RBC Capital Markets analyst Nik Modi initiated coverage of
Utz
stock (ticker: UTZ) with an Outperform rating and a $17 price target, implying a 25% increase to the stock’s Monday closing price. This bullish initiation comes after shares of the maker of potato chips, cheeseballs, pretzels, and more salty treats have dropped 13% this year.

One reason for Wall Street’s concern is the recent popularity of weight-loss drugs like Mounjaro, Ozempic, and Wegovy, and what that could mean for the snack food industry.
Novo Nordisk’s
(NVO) Ozempic and
Eli Lilly’s
(LLY) Mounjaro are two diabetes drugs being used by some for weight management. while Novo’s Wegovy has been approved for weight loss.

Modi wrote in a research note Tuesday that some investors are concerned by what the growing popularity of these drugs could mean for the stock, especially since they cause users to have a smaller appetite and require the people taking them to eat healthy foods to see results.

“We are not in this camp,” Modi said. “We must not forget that these drugs are expensive and out of reach for many Americans seeking to use them for weight loss as a result.”

“Consumption of indulgent salty snacks that would be considered ‘junk food’ generally over-indexes toward lower-income individuals, who are unlikely to be these drugs’ primary users,” the analyst added.

Modi also recognized that there are other concerns within the snack space as consumers continue to feel the pinch of high grocery prices as inflation runs hot. With prices historically high, shoppers may choose to trade down to store brands or avoid buying snacks altogether.

The analyst says these pressures will continue in the near term, but the stock is compelling for investors willing to wait.

“
Utz
is a pure-play salty snack company—which is one of the most attractive segments of the consumer-staples industry due to its faster growth, low exposure to private label and structural long-term drivers such as growth in smaller households and snacking extending to more occasions,” Modi said. “In addition, we believe Utz has significant opportunity to extend its geographic reach as its current sales base is concentrated in Northeast and Mid-Atlantic.”

Utz stock is rising 1.7% Tuesday to $13.80.

Write to Angela Palumbo at [email protected]

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Even Time-Strapped Business Owners Can Share an Engaging Reading Experience with Their Kids

Investing September 20, 2025

Turnover Is Costing You More Than You Think — Here’s the Fix

Investing September 19, 2025

How Pana Food Truck Started Selling Arepas

Investing September 18, 2025

Amazon CEO Andy Jassy Is Fighting Against Bureaucracy

Investing September 17, 2025

Here Are the Top 50 Mistakes I’ve Seen Kill New Companies

Investing September 16, 2025

Google Parent Alphabet Reaches $3T Market Cap

Investing September 15, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

21 Thrift Store Gems You Can Cash in On

September 24, 20250 Views

Principles For A Successful Financial Year

September 23, 20250 Views

10 Things You Can Get for Free at Pharmacies

September 23, 20250 Views

Nearly Half of Workers Admit to Revenge Quitting. Here’s Why.

September 23, 20250 Views
Don't Miss

Build-A-Bear Workshop Outpaces Nvidia, Microsoft, Oracle

By News RoomSeptember 23, 2025

Nvidia may be the most valuable company in the world, surging to a record-high $4.395…

Spirit Airlines Furloughing Flight Attendants, Cutting Routes

September 22, 2025

Stellantis Data Breach Affects Millions of Car Buyers: Report

September 22, 2025

How Inflation Sneaks Up On Retirees

September 22, 2025
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 FintechoPro. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.